University of California, San Francisco    About UCSF    Search UCSF    UCSF Medical Center    Department of Surgery Websites    
Thoracic Oncology Program
Thoracic Oncology Programs & Labs
Department of Surgery Websites

Message from the Director

David M. Jablons, M.D.
Professor and Chief, Thoracic Surgery
Program Leader, Thoracic Oncology Program

New Lung Cancer Test Predicts Survival

In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by UCSF thoracic surgeons David M. Jablons, M.D.  and Michael Mann, M.D.  (pictured left) demonstrated that a molecular test can better predict the likelihood of death from early-stage lung cancer than conventional methods.

Audio Interview with The Lancet >>

Make a Gift

A gift to the Thoracic Oncology Progam helps us discover new treatments and cures for lung cancer, esophageal cancer and mesothelioma.

A Powerful and Passionate Combination

top logo gradientLung cancer is the leading cause of cancer death worldwide and the Thoracic Oncology Program is poised to conquer it. UCSF provides state-of-the-art care to patients with lung cancer, mesothelioma, esophageal cancer, sarcoma and cancer that has metastasized to the chest. The program is led by David M. Jablons, M.D., Chief of the Section of General Thoracic Surgery and Program Leader of the Thoracic Oncology Program. Patients receive treatment from a dedicated multidisciplinary team of specialists. At UCSF, one of the world's leading biomedical research centers, patients also have access to clinical trials for promising new drugs.

1-26-2012 9-41-16 PM